ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2024
Quantitative
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy.Circulation. Cardiovascular imaging · 2026Article
- Infiltrative and Inflammatory Cardiomyopathies: Using Imaging to Probe Mechanisms of Myocardial Dysfunction.Journal of cardiac failure · 2026Review
- Biomarker-Imaging Dissociation in Wild-Type Cardiac Amyloidosis after Treatment with Patisiran.Arquivos brasileiros de cardiologia · 2026Article
- Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging.European heart journal. Cardiovascular Imaging · 2026Review
- Artificial intelligence-driven longitudinal quantification of technetium pyrophosphate uptake in cardiac amyloidosis: Correlation with multimodality imaging and outcomes.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026Article
- QuantitativeAsia Oceania journal of nuclear medicine & biology · 2026Article
- Multimodality Imaging in Cardiac Amyloidosis.Journal of clinical medicine · 2025Review
- Prognostic value ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2025Article
- Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.JACC. Cardiovascular imaging · 2025Review
- From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging.Journal of clinical medicine · 2025Review
- The Accuracy of Technetium-99 m Pyrophosphate Imaging in Diagnosing Transthyretin Cardiac Amyloidosis and Its Impact on Patient Management.Current cardiology reports · 2025Review
- Monitoring ATTR cardiomyopathy - addressing an unmet need by multimodality imaging.The international journal of cardiovascular imaging · 2025Article
- Evolution of cardiac amyloidosis imaging with bone-avid tracers: From qualification to quantification.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
backgroundQuantitative technetium-99m-pyrophosphate cardiac single-photon emission computed tomography (
methodsThis prospective longitudinal cohort study investigated changes in
resultsFollowing therapy, visual grade decreased significantly (P = 0.003). Several quantitative
conclusionsFavorable changes in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.